Financial Modeling
Financial Modeling
Financial Modeling
Expecting growth % of
Sales 10.00%
Export incentive linked to export sales growth 9%
Other Revenue from operation excluding export incentive 3%
Other Income Assuming the deposits are declining -16%
Assuming no PPE sold in next 5 years 0%
Assuming emplyee benefit expense at inlation rate 5.40%
Assuming the company is keeping the loan amount at same level
Assuming there is no future contingencies 0.00%
A Sales
F Expenses
1 Cost of materials consumed 76,521.10
2 Purchases of stock-in-trade 3,480.20
3 Changes in inventories of finished goods, work-in-progress and stock-in-trade -2,502.70
4 Employee benefits expense 16,354.60
5 Finance costs (including interest cost on employee benefit plans) 1,545.70
6 Depreciation and Amortisation 4,030.10
7 Other expenses 36,970.50
8 Impairment loss on property, plant and equipment 294.30
9 Net provision for contingencies - Others 162.90
10 Corporate social responsibility expense 563.20
1 Non-current assets
2 Current assets
1 EQUITY
2 LIABILITIES
a Non-current liabilities
Financial Liabilities
Borrowings 266.6 293.26
Lease liabilities 1,906.50 1,811.18
Provisions 32,051.60 33654.18
Other non-current liabilities 173.5 173.5
b Current liabilities
Net increase in Cash and Cash Equivalents 23,848 27,953 31,984 36,354
Cash and Cash Equivalents at beginning of period 9,266 33,114 61,067 93,051
Cash and Cash Equivalents at end of period 33114 61067 93051 129405
2027
67,918
8,731
913
77,562
-4,031
-262
-3,121
3,183
622
73,953
17,564
56,389
-18,864
-820.17418
-221.59
3,338.00
-16,568
66.90
-78
-196
-913
1,253
41,075
129,405
170480